Published in Lancet on September 08, 1984
Functional anatomy of the lymphocyte in immunological reactions in vitro. J Exp Med (1966) 2.91
A collaborative scheme for tissue typing and matching in renal transplantation. Lancet (1969) 2.26
Wegener's granulomatosis: observations on 18 patients with severe renal disease. Q J Med (1983) 2.07
Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet (1982) 1.98
Factors affecting the reactivity of human lymphocytes in vitro. I. Cell number, duration of culture and surface area. J Immunol (1967) 1.96
The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Invest (1995) 1.91
Association of primary sclerosing cholangitis with HLA-B8. Gut (1983) 1.79
Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation. Kidney Int (2001) 1.71
Plasma-exchange and immunosuppression in the treatment of fulminating immune-complex crescentic nephritis. Lancet (1977) 1.71
Serum ferritin assay and iron status in chronic renal failure and haemodialysis. Br Med J (1975) 1.61
Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft. Lancet (1980) 1.60
Abdominal hernias in patients receiving continuous ambulatory peritoneal dialysis. Br Med J (Clin Res Ed) (1981) 1.59
Does oral folic acid lower total homocysteine levels and improve endothelial function in children with chronic renal failure? Circulation (2002) 1.58
Cancer in patients receiving dialysis. Br Med J (1980) 1.52
Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown. Cancer Res (1990) 1.51
The polyneuropathy of chronic renal failure. Brain (1971) 1.49
Influence of HLA matching and blood-transfusion on outcome of 502 London Transplant Group renal-graft recipients. Lancet (1976) 1.47
Post-renal transplant distal limb bone pain. An under-recognized complication of transplantation distinct from avascular necrosis of bone? Transplantation (1995) 1.45
Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther (2007) 1.45
Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet (1988) 1.41
Low-dose vs high-dose intravenous methylprednisolone therapy for acute renal allograft rejection in patients receiving cyclosporin therapy. Nephrol Dial Transplant (1989) 1.39
Cyclosporin-induced renal magnesium leak in renal transplant patients. Nephrol Dial Transplant (1990) 1.38
Influence of HL-A matching antigenic strength, and immune responsiveness on outcome of 349 cadaver renal grafts. 3 years' experience of the London transplant group. Lancet (1972) 1.36
Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir. J Infect Dis (2004) 1.35
Sixteen months experience with cyclosporin-A in human kidney transplantation. Transplant Proc (1981) 1.35
Atherosclerotic renovascular disease causing renal impairment--a case for treatment. Clin Nephrol (1989) 1.28
Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease. J Gen Virol (1995) 1.26
Multicentre collaboration in 162 tissue-typed renal transplants. The London and Regional Transplant Group, March, 1969, to December, 1970. Lancet (1971) 1.25
Hepatitis-associated antigen and antibody in haemodialysis patients and staff. Br Med J (1970) 1.23
Rhabdomyolysis and systemic infection. Br Med J (Clin Res Ed) (1983) 1.22
Clinical, biochemical, and histological studies of osteomalacia, osteoporosis, and parathyroid function in chronic liver disease. Gut (1978) 1.19
Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation. Am J Transplant (2008) 1.19
Glycosylated haemoglobin in chronic renal failure. Br Med J (1979) 1.16
Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation. J Med Virol (1997) 1.15
Lipid abnormalities in uremia, dialysis, and transplantation. Kidney Int (1981) 1.15
Recurrent hyperinfestation with Strongyloides stercoralis in a renal allograft recipient. Br Med J (Clin Res Ed) (1982) 1.13
On the binding of chitin oligosaccharides to lysozyme. Proc Natl Acad Sci U S A (1966) 1.12
Long-term T-cell-mediated immunity to Epstein-Barr virus in renal-allograft recipients receiving cyclosporin A. Lancet (1981) 1.11
Lymphoid inhibitor of human lymphocyte DNA synthesis and mitosis in vitro. Nature (1969) 1.11
Atrial thrombus and central venous dialysis catheters. Am J Kidney Dis (2001) 1.11
Thrombotic thrombocytopenic purpura. Recovery after splenectomy. Arch Intern Med (1966) 1.11
Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha-tocopherol. J Biol Chem (1998) 1.11
The relationship between the circulating concentrations of interleukin 6 (IL-6), tumor necrosis factor (TNF) and the acute phase response to elective surgery and accidental injury. Lymphokine Res (1990) 1.10
Home dialysis in children and adolescents. Proc Eur Dial Transplant Assoc (1972) 1.09
Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients. J Immunol (1998) 1.09
Oxidation of methionine residues to methionine sulfoxides does not decrease potential antiatherogenic properties of apolipoprotein A-I. J Biol Chem (2000) 1.05
Plasma hydroxyproline in renal osteodystrophy. Proc Eur Dial Transplant Assoc (1973) 1.04
In situ detection of tumour necrosis factor in human ovarian cancer specimens. Eur J Cancer (1990) 1.03
Prospective study of human betaherpesviruses after renal transplantation: association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection. Transplantation (2000) 1.03
Persistent hypophosphataemia and osteomalacia in dialysis patients not on oral phosphate-binders: Response to dihydrotachysterol therapy. Lancet (1976) 1.03
A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population. Am J Transplant (2012) 1.02
Efficiency of scintillation counting of tritium labelled DNA-protein in the mixed leucocyte reaction in vitro. Nature (1966) 1.02
Phenytoin-induced pseudolymphoma. A report of a case and review of the literature. Br J Dermatol (1992) 1.00
Disorders of blood-lipids in renal disease. Lancet (1975) 0.99
Parenteral 1,25-dihydroxycholecalciferol in hepatic osteomalacia. Br Med J (1978) 0.99
Renal physiology revisited: amiloride. Lancet (1986) 0.98
Rejection encephalopathy. Proc Eur Dial Transplant Assoc (1981) 0.98
Vitamin A toxicity and hypercalcaemia in chronic renal failure. Br Med J (Clin Res Ed) (1981) 0.97
Parathyroid hormone as a causative factor of primary non-function in renal transplants. Br Med J (Clin Res Ed) (1988) 0.97
The effect of cyclosporin A on peripheral blood T cell subpopulations in renal allografts. Clin Exp Immunol (1982) 0.96
Studies on long-term T-cell-mediated immunity to Epstein-BArr virus in immunosuppressed renal allograft recipients. Int J Cancer (1981) 0.96
Significance of high plasma renin activity in patients on maintenance haemodialysis therapy. Br Med J (1973) 0.96
Captopril-enhanced 99mTc DTPA scintigraphy in the detection of renal-artery stenosis. Nephrol Dial Transplant (1988) 0.96
Acyclovir in hepatitis B antigen-positive chronic liver disease: inhibition of viral replication and transient renal impairment with iv bolus administration. J Antimicrob Chemother (1983) 0.96
Insulin resistance and iron overload. Ann Clin Biochem (1983) 0.96
Effect of fluvastatin on acute renal allograft rejection: a randomized multicenter trial. Kidney Int (2001) 0.96
Plasma renin activity and blood pressure in 89 patients receiving maintenance haemodialysis therapy. Br Med J (1972) 0.95
Glomerular structures and lipids in progressive renal disease. Am J Med (1989) 0.95
Gut hormones and glomerular hyperfiltration. Lancet (1984) 0.94
Specific molecular aggregates or Torpedo californica acetylcholine receptor. Biochem Biophys Res Commun (1978) 0.94
Acute tubular necrosis due to rhabdomyolysis and pancreatitis associated with Salmonella enteritidis food poisoning. Nephrol Dial Transplant (1993) 0.94
Hypophosphataemic osteomalacia after cadaveric renal transplantation. Lancet (1974) 0.93